Published on in Vol 8, No 7 (2022): July

Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study

Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study

Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study

Journals

  1. Manzotti C, Chulo L, López del Campo R, Trias I, del Pino M, Saúde O, Basílio I, Tchamo N, Lovane L, Lorenzoni C, Fernandes F, Saco A, Rodrigo-Calvo M, Marimon L, Ismail M, Carrilho C, Ribera-Cortada I, Ordi J, Rakislova N. Penile Squamous Cell Carcinomas in Sub-Saharan Africa and Europe: Differential Etiopathogenesis. Cancers 2022;14(21):5284 View
  2. Peak T, Zemp L, Spiess P. Will Dynamic Sentinel Lymph Node Biopsy Surpass Inguinal Lymph Node Dissection in High-risk Node-negative Penile Cancer?. European Urology Oncology 2022;5(6):712 View
  3. Almaghlouth A, Bohamad A, Alabbad R, Alghanim J, Alqattan D, Alkhalaf R. Acceptance, Awareness, and Knowledge of Human Papillomavirus Vaccine in Eastern Province, Saudi Arabia. Cureus 2022 View
  4. Brouwer O, Albersen M, Parnham A, Protzel C, Pettaway C, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fernández-Pello S, Greco I, van der Heijden M, Johnstone P, Kailavasan M, Manzie K, Marcus J, Necchi A, Oliveira P, Osborne J, Pagliaro L, Garcia-Perdomo H, Rumble R, Sachdeva A, Sakalis V, Zapala Ł, Sánchez Martínez D, Spiess P, Tagawa S. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. European Urology 2023;83(6):548 View
  5. Xue T, Li Z, Wu C, Li Y, Liu Z, Qin Z, Yao K, Zhou F, Han H. Prognostic Value of Inflammation Biomarkers in Penile Squamous Cell Carcinoma Patients Without Distant Metastasis. Clinical Genitourinary Cancer 2023;21(5):e334 View
  6. Drevinskaite M, Patasius A, Kincius M, Jonušas J, Ladukas A, Jievaltas M, Kairevice L, Smailyte G. Incidence, mortality and survival trends of penile cancer in Lithuania 1998–2017. Frontiers in Oncology 2023;13 View
  7. Ashley L, Sutton K, Ju A, Edwards G, Pasli M, Bhatt A. A SEER database retrospective cohort of 547 patients with penile non-squamous cell carcinoma: demographics, clinical characteristics, and outcomes. Frontiers in Oncology 2023;13 View
  8. Moen C, Falkenthal T, Thorkelsen T, Hopland A, Rio O, Honoré A, Juliebø-Jones P, Dongre H, Costea D, Bostad L, Brennan P, Johansson M, Ferreiro-Iglesias A, Brenner N, Waterboer T, Nygård M, Beisland C. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. European Urology Oncology 2024;7(4):778 View
  9. Mink J, Khalmurzaev O, Pryalukhin A, Hölters S, Geppert C, Lohse S, Bende K, Lobo J, Henrique R, Loertzer H, Steffens J, Jerónimo C, Wunderlich H, Heinzelbecker J, Bohle R, Stöckle M, Matveev V, Hartmann A, Junker K. Bedeutung von HPV-Status und p16 für die Prognose des Peniskarzinoms. Aktuelle Urologie 2023;54(04):274 View
  10. Tekin B, Cheville J, Herrera Hernandez L, Negron V, Smith C, Jenkins S, Dasari S, Enninga E, Norgan A, Menon S, Cubilla A, Whaley R, Jimenez R, Thompson R, Leibovich B, Karnes R, Boorjian S, Pagliaro L, Erickson L, Guo R, Gupta S. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Human Pathology 2023;142:42 View
  11. Parza K, Mustasam A, Ionescu F, Paravathaneni M, Sandstrom R, Safa H, Grass G, Johnstone P, Eschrich S, Chadha J, Zacharias N, Pettaway C, Spiess P, Chahoud J. The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review. Cancers 2023;15(14):3713 View
  12. Sangkhamanon S, Kotano N, Sirithanaphol W, Rompsaithong U, Kiatsopit P, Sookprasert A, Wirasorn K, Twinprai P, Watcharenwong P, Chindaprasirt J. Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer. Biomedical Reports 2023;19(1) View
  13. Zhang F, Luo J, Tian Y, Tang B, Lv H, Liu H, Zhang J. Allergic Rhinitis and Cancer Risk: A Two-Sample Mendelian Randomization Study. Genetic Testing and Molecular Biomarkers 2023;27(9):269 View
  14. Mink J, Khalmurzaev O, Pryalukhin A, Geppert C, Lohse S, Bende K, Lobo J, Henrique R, Loertzer H, Steffens J, Jerónimo C, Wunderlich H, Heinzelbecker J, Bohle R, Stöckle M, Matveev V, Hartmann A, Junker K. Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas. Cancers 2023;15(19):4748 View
  15. Guimaraes M, Macieira R, Azevedo F, Lisboa C. Association between HPV infection and penile cancer and penile intraepithelial neoplasia: A retrospective observational study. Journal of the European Academy of Dermatology and Venereology 2024;38(1):186 View
  16. Yang S, Chang W, Zhang B, Hou Q, Zhang B, Kang Y, Yin Y, Wan J, Shang P. Development and validation of a predictive model for penile cancer based on the surveillance, epidemiology, and end results database and multi-center cases. Journal of Cancer Research and Clinical Oncology 2023;149(15):13665 View
  17. White J, Mason R, Lawen T, Spooner J, Faria K, Rahman F, Ramasamy R. Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments. Research and Reports in Urology 2023;Volume 15:165 View
  18. Zhou X, Tian T, Lu Z, Yu Y, Li Y, Zhou Y, Lin Y, Strong C, Zou H. Incidence, persistence, and clearance of anogenital human papillomavirus among men who have sex with men in Taiwan: a community cohort study. Frontiers in Immunology 2023;14 View
  19. Tampakoudis G, Anastasiou O. Burden of HPV-Related Hospitalization in Germany from 2000 to 2021. Viruses 2023;15(9):1857 View
  20. Nazha B, Zhuang T, Wu S, Brown J, Magee D, Carthon B, Kucuk O, Nabhan C, Barata P, Heath E, Ryan C, McKay R, Master V, Bilen M. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer 2023;129(24):3884 View
  21. Di Martino G, Cedrone F, Di Giovanni P, Tognaccini L, Trebbi E, Romano F, Staniscia T. The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015–2021 from a Southern Italian Region. Pathogens 2023;12(5):725 View
  22. Fu L, Tian T, Wang B, Lu Z, Gao Y, Sun Y, Lin Y, Zhang W, Li Y, Zou H. Global patterns and trends in Kaposi sarcoma incidence: a population-based study. The Lancet Global Health 2023;11(10):e1566 View
  23. Akinyemi O, Fasokun M, Weldeslase T, Adeoye O, Coleman P. Influence of Race/Ethnicity and Household Median Income on Penile Cancer Mortality. Cureus 2023 View
  24. Crook J. The role of radiotherapy in the management of squamous cell cancer of the penis. World Journal of Urology 2023;41(12):3913 View
  25. Huang J, Chan S, Pang W, Liu X, Zhang L, Lucero‐Prisno D, Xu W, Zheng Z, Ng A, Necchi A, Spiess P, Teoh J, Wong M. Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study. BJU International 2023 View
  26. Ortiz-Guerra R, Jaime-Casas S, Martinez-Cannon B, Ariza-Avila J, González-Morales A, Bardan-Duarte A, Remolina-Bonilla Y, Spiess P, Bourlon M. Overview and characterization of penile cancer content across social media platforms. Frontiers in Oncology 2023;13 View
  27. Yudiana I, Marta S, Sugianto R, Lestari A. Programmed Death-Ligand 1, C-reactive Protein, and Neutrophil/Lymphocyte Ratio as Lymphangiogenesis Markers of Metastasis in Penile Cancer – A Systematic Review. Forum of Clinical Oncology 2024;0(0) View
  28. Zhang M, Chen Z, Liu X, Liu J. Influencing factors of Chinese male circumcision acceptance willingness: a health belief model approach. Current Psychology 2024;43(20):18474 View
  29. Chung E, Shin B, Wang J. Editorial comment on Differences in overall survival of penile cancer patients vs. population‐based controls. International Journal of Urology 2024;31(3):280 View
  30. Vreeburg M, de Vries H, van der Noort V, Horenblas S, van Rhijn B, Hendricksen K, Graafland N, van der Poel H, Brouwer O. Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival. BJU International 2024;133(5):596 View
  31. Ilgeldiev S, Tabidze D, Stoeckel S, Rudolph H, Mirow L. Differential diagnoses of inguinal swellings: a case series of atypical diagnoses. Journal of Surgical Case Reports 2024;2024(3) View
  32. Falcone M, Gül M, Peretti F, Preto M, Cirigliano L, Scavone M, Sedigh O, Oderda M, Gontero P. Inguinal Lymphadenectomy for Penile Cancer: An Interim Report from a Trial Comparing Open Versus Videoendoscopic Surgery Using a Within-patient Design. European Urology Open Science 2024;63:31 View
  33. Vandermaesen K, Albersen M. Young men with penile cancer fare as poorly as elder patients: clinical implications. International Journal of Impotence Research 2024 View
  34. Ayres B. Psychosocial Impact of Penile Cancer. Urologic Clinics of North America 2024;51(3):327 View
  35. Eismann L, Ledderose S, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz G, Toms J, Holzgreve A, Gildehaus F, Brendel M, Cyran C, Unterrainer M, Stief C, Bartenstein P, Schlenker B, Unterrainer L. [68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study. European Journal of Nuclear Medicine and Molecular Imaging 2024 View
  36. Zemp L, Rudzinski J, Pettaway C, Nicholson S, Spiess P. Management of Bulky Inguinal and Pelvic Lymph Nodes. Urologic Clinics of North America 2024;51(3):335 View
  37. Simon N, Atiq S, Sonpavde G, Apolo A. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer. Urologic Clinics of North America 2024;51(3):367 View
  38. Thumma N, Pitla N, Gorantla V, du Plessis M. A comprehensive review of current knowledge on penile squamous cell carcinoma. Frontiers in Oncology 2024;14 View
  39. Velasquez D, Liu A, Kalidoss S, Yeaman C, Bryk D, Fustok J, Shelton T, Alhameedi H, Payakachat N, Kamel M, Ledesma B, Khalil M, Smith R, Raheem O. Comparative outcomes of partial versus total penectomy for penile carcinoma: A retrospective cohort study on demographics and postoperative complications. International Journal of Impotence Research 2024 View
  40. Xu D, Zhuang X, Ma H, Li Z, Wei L, Luo J, Han H. Altered tumor microenvironment heterogeneity of penile cancer during progression from non‐lymphatic to lymphatic metastasis. Cancer Medicine 2024;13(14) View
  41. Zhang L, Zhuang X, Yang X, Xu F, Wang N, Guo Z, Chen J, Ding D. Analysis of hospitalization expenses and influencing factors for elderly cancer patients in a tertiary hospital in Dalian, China: a five‑year retrospective study. BMC Cancer 2024;24(1) View
  42. Nijboer T, van der Fels C, de Wit J, Keizers B, Huizinga H, Voskuil F, Voskamp M, van den Heuvel M, Witjes M, de Jong I. Fluorescence‐guided surgery using cetuximab‐800CW in patients with penile carcinoma. BJU International 2024;134(2):268 View
  43. Avitan O, Rafael T, Vreeburg M, Elst L, Bekers E, Albersen M, Jordanova E, Brouwer O. Penile intraepithelial neoplasia incidence, clinical classification, microenvironment and implications for imiquimod treatment. BJU International 2024 View